Concepts (79)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drug Resistant Epilepsy | 11 | 2025 | 248 | 3.090 |
Why?
|
| Hypothalamic Diseases | 4 | 2022 | 38 | 1.660 |
Why?
|
| Hamartoma | 4 | 2022 | 49 | 1.650 |
Why?
|
| Epilepsy | 5 | 2024 | 844 | 1.150 |
Why?
|
| Laser Therapy | 7 | 2025 | 230 | 1.120 |
Why?
|
| Tuberous Sclerosis | 3 | 2025 | 135 | 1.110 |
Why?
|
| Vagus Nerve Stimulation | 3 | 2024 | 59 | 1.080 |
Why?
|
| Deep Brain Stimulation | 3 | 2024 | 402 | 0.780 |
Why?
|
| Spasms, Infantile | 1 | 2020 | 165 | 0.580 |
Why?
|
| Stereotaxic Techniques | 3 | 2025 | 88 | 0.450 |
Why?
|
| Seizures | 6 | 2025 | 847 | 0.440 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2025 | 3696 | 0.370 |
Why?
|
| Treatment Outcome | 11 | 2025 | 12563 | 0.330 |
Why?
|
| Child, Preschool | 11 | 2025 | 14444 | 0.270 |
Why?
|
| Young Adult | 8 | 2025 | 9693 | 0.260 |
Why?
|
| Child | 12 | 2025 | 25277 | 0.250 |
Why?
|
| Retrospective Studies | 9 | 2025 | 17043 | 0.220 |
Why?
|
| Thalamic Nuclei | 1 | 2024 | 18 | 0.220 |
Why?
|
| Adolescent | 9 | 2025 | 20135 | 0.210 |
Why?
|
| Electroencephalography | 2 | 2025 | 821 | 0.200 |
Why?
|
| Electric Stimulation Therapy | 1 | 2024 | 79 | 0.200 |
Why?
|
| Vocal Cord Paralysis | 1 | 2024 | 66 | 0.200 |
Why?
|
| Drug Hypersensitivity | 1 | 2024 | 97 | 0.200 |
Why?
|
| Hemispherectomy | 1 | 2023 | 26 | 0.200 |
Why?
|
| Laryngoscopy | 1 | 2024 | 157 | 0.190 |
Why?
|
| Anticonvulsants | 1 | 2024 | 376 | 0.180 |
Why?
|
| Verbal Learning | 1 | 2022 | 67 | 0.180 |
Why?
|
| Humans | 19 | 2025 | 127201 | 0.180 |
Why?
|
| Philadelphia Chromosome | 1 | 2021 | 42 | 0.180 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 1 | 2021 | 20 | 0.180 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2021 | 102 | 0.170 |
Why?
|
| Tumor Burden | 1 | 2020 | 229 | 0.150 |
Why?
|
| Translocation, Genetic | 1 | 2021 | 348 | 0.150 |
Why?
|
| Male | 13 | 2025 | 62767 | 0.150 |
Why?
|
| Female | 13 | 2025 | 68579 | 0.150 |
Why?
|
| Memory | 1 | 2022 | 346 | 0.140 |
Why?
|
| Infant | 6 | 2025 | 12801 | 0.140 |
Why?
|
| Cohort Studies | 3 | 2025 | 4976 | 0.140 |
Why?
|
| Bell Palsy | 1 | 2014 | 6 | 0.110 |
Why?
|
| Quality of Life | 1 | 2024 | 2033 | 0.110 |
Why?
|
| Herpesvirus 3, Human | 1 | 2014 | 30 | 0.100 |
Why?
|
| Herpesvirus 1, Human | 1 | 2014 | 33 | 0.100 |
Why?
|
| Biomarkers, Tumor | 1 | 2021 | 1560 | 0.100 |
Why?
|
| Adult | 4 | 2024 | 30513 | 0.080 |
Why?
|
| Magnetoencephalography | 1 | 2025 | 41 | 0.060 |
Why?
|
| Kentucky | 1 | 2024 | 27 | 0.060 |
Why?
|
| Electrodes, Implanted | 1 | 2025 | 168 | 0.060 |
Why?
|
| Dysphonia | 1 | 2024 | 16 | 0.050 |
Why?
|
| Vocal Cords | 1 | 2024 | 60 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2025 | 5139 | 0.050 |
Why?
|
| Neck | 1 | 2024 | 141 | 0.050 |
Why?
|
| Electrocorticography | 1 | 2023 | 55 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2023 | 276 | 0.050 |
Why?
|
| Imatinib Mesylate | 1 | 2021 | 47 | 0.040 |
Why?
|
| Drug Substitution | 1 | 2021 | 24 | 0.040 |
Why?
|
| Karyotyping | 1 | 2021 | 312 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2022 | 326 | 0.040 |
Why?
|
| Epilepsies, Partial | 1 | 2020 | 84 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2025 | 2233 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2021 | 748 | 0.040 |
Why?
|
| Middle Aged | 3 | 2024 | 27789 | 0.040 |
Why?
|
| Pyrimidines | 1 | 2021 | 407 | 0.040 |
Why?
|
| Electrocoagulation | 1 | 2018 | 32 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2022 | 951 | 0.040 |
Why?
|
| Electronic Health Records | 1 | 2024 | 781 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2020 | 590 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2021 | 576 | 0.030 |
Why?
|
| Incidence | 1 | 2024 | 3260 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2018 | 379 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2022 | 3325 | 0.030 |
Why?
|
| Hydroxycorticosteroids | 1 | 2014 | 1 | 0.030 |
Why?
|
| Herpes Simplex Virus Protein Vmw65 | 1 | 2014 | 10 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2025 | 3072 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 1758 | 0.020 |
Why?
|
| Brain | 1 | 2022 | 3039 | 0.020 |
Why?
|
| Disease Management | 1 | 2014 | 544 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2014 | 1203 | 0.020 |
Why?
|
| Aged | 1 | 2024 | 20414 | 0.020 |
Why?
|
| Prognosis | 1 | 2014 | 4785 | 0.010 |
Why?
|